Pricing Log in Create free account

Bruker Corporation (BRKR) vs 10x Genomics (TXG)

Bruker Corporation and 10x Genomics are both Medical Devices companies. Bruker Corporation is the larger, with a market value of $8.9B against $7.6B — 1.2× the size. Bruker Corporation grew revenue faster over the last twelve months: 2.16% against −4.28%. Bruker Corporation has the higher net margin (−4.76% vs −12.2%) and the higher return on invested capital (−1.12% vs −20.2%). Across the 19 metrics below, Bruker Corporation leads on 12 and 10x Genomics on 7.

Valuation

Metric BRKR TXG Medical Devices median
P/E n/m n/m 25.58
P/S 2.53 12.35 2.54
P/B 3.70 9.23 2.48
Price to free cash flow 32.93 63.28 28.81
EV/EBITDA 65.97 n/m 11.51
EV/Sales 2.98 11.51 2.72
Earnings yield (1.73%) (1.01%) (12.82%)
Free cash flow yield 3.04% 1.58% (8.18%)

Profitability

Metric BRKR TXG Medical Devices median
Gross margin 47.66% 70.03% 57.76%
Operating margin (1.99%) (14.33%) (15.07%)
Net margin (4.76%) (12.18%) (14.45%)
Free cash flow margin 6.97% 19.68% (3.88%)
Return on equity (7.04%) (9.40%) (10.35%)
Return on assets (2.73%) (7.47%) (17.26%)
Return on invested capital (1.12%) (20.20%) (5.27%)

Growth

Metric BRKR TXG Medical Devices median
Revenue growth (TTM) 2.16% (4.28%) 10.41%
EPS growth (last fiscal year) (119.74%) 76.97% 28.17%
Revenue growth, 5-year CAGR 11.57% 16.55% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BRKR TXG Medical Devices median
Debt to equity 0.74 0.00 0.04
Current ratio 1.84 5.69 2.74
Net debt to EBITDA 5.44 30.49 0.54

Dividend

Metric BRKR TXG Medical Devices median
Dividend yield 0.34% — 1.02%
Payout ratio — — 0.37

Size

Metric BRKR TXG Medical Devices median
Market cap 8.85b 7.56b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack